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Foreign antigenic moieties are recognized by T lymphocytes in association
with products of the MHC. Both class I MHC products (e.g., H-2 K/LD locus
products in the mouse) and class II MHC products (e.g., murine H-2 I locus
products) restrict T lymphocyte recognition of antigen (1). The mechanism by
which antigen and MHC products are presented to T lymphocytes is not
completely understood. Recently, however, studies by Babbit et al . (2) and Buus
et al. (3) have indicated that a direct interaction between class II MHC products
and processed forms of foreign antigens may constitute a critical step in the
formation of the antigen moiety recognized by class II MHC-restricted T
lymphocytes. Although the pathways of antigen presentation to class I and class
II MHC-restricted T lymphocytes appear to be distinctly different (4), there is
evidence that class I MHC-restricted T lymphocytes may also recognize pro-
cessed forms of foreign antigens (5-10).
In this report we have examined the recognition of the type A influenza virus
hemagglutinin (HA)' by class I MHC-restricted CTL with particular emphasis
on the role of the hydrophobic transmembrane anchor sequence in the formation
of the HA antigenic structure necessary for target cell recognition by H-2Kd-
restricted HA-specific CTL . We have observed that the product of a truncated
HA gene that lacks the sequence corresponding to the hydrophobic anchor and
cytoplasmic domains of the A/JAP/305/57 HA can be recognized by a majority
of H-2K'-restricted HA-specific CTL . Further, transmembrane sequence itself
appears to contain amino acid residues that make up antigenic epitopes recog-
nized by H2N2 subtype-specific and crossreactive HA-specific CTL clones. The
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implications of these observations for viral antigen presentation in class I MHC
CTL recognition are discussed .
Materials and Methods
Viruses.
￿
Influenza virus strains A/JAP/57 (A/Japan/305/57 [H2N2]), and B/Lee were
grown in the allantoic cavity of I 0-d-old embryonated chicken eggs and stored as infectious
allantoic fluid as previously described (11). SV40 virus stocks were produced as described
by Doyle et al . (12). A recombinant vaccinia virus containing the A/JAP/57 gene (13, 14)
was kindly provided by Dr. Bernard Moss. (National Institutes of Health, Bethesda, MD.)
Cell Lines.
￿
Low-passage CV-1 monkey cells were obtained from the American Type
Culture Collection (Rockville, MD) and were passaged and maintained in Dulbecco's
Modified Minimal Essential Medium (DME) supplemented with 10% (vol/vol) FCS.
CVKD-10.6 cells, a neomycin-resistant derivative of the CV-1 cell line that expresses the
murine H-2K' gene product, were maintained in the above medium further supplemented
with the antibiotic G418 (Gibco Laboratories, Grand Island, NY) at a final concentration
of 400,ug/ml. The protocols for maintenance of P815 cells in DME plus 10% FCS and of
parental L cells (line K2) or transfected L cells expressing the Kd gene product in (line
K7-74) HAT selection medium have been described previously (15, 16).
Recombinant SV40 Expression Vectors.
￿
The construction and characterization of SV40-
based late replacement vectors designed to express the wild-type and mutant A/JAP/57
HA molecules shown in Figure 2 have been described previously. The recombinant
viruses used to express the various HA species were as follows: SVEHA3 [wild-type HA
(17)]; SVEHA20-A- (anchor-negative HA [18]); SVEHA-G and SVEHA-gC (chimeric
HAs containing the transmembrane and cytoplasmic domains of the VSV G glycoprotein
and the HSV-1 C glycoprotein, respectively [19]). High-titer, second-passage (P2) virus
stocks were generated as described previously (12), but the following modified protocol
was used to infect CVKD-10.6 cells. Monolayers of exponentially growing cells were
harvested by trypsinization and washed with DME containing 10% FCS . Aliquots of 9 X
105 cells were resuspended in 100 tl of undiluted P2 virus stocks, incubated on ice for 10
min and then at 37°C for 60 min. After the addition of 5 ml of DME plus 10% FCS, the
cells were plated in 60-mm culture dishes or 75-cm' flasks and incubated at 37 °C in an
atmosphere of 5% C02 for 48-72 h before assay for expression of HA.
Isolation of Monkey CV-1 Cells that Express the Murine K° Gene Product.
￿
CV-1 cell
transformants that express the product of the Kd gene were established by cotransfection
with DNA corresponding to this gene segment together with the bacterial gene that
encodes resistance to the antibiotic G418 . Antibiotic-resistant cell colonies were isolated
and analyzed for expression of the Kd gene product by RIA (15). Several positive cell
lines were then tested for cell surface expression of the K product by flow cytofluorometry
using a murine mAb (D04) as described previously (20, 21). From the cell line expressing
the highest level of Kd, the brightest 10% of cells were sorted, grown up, and subjected
to sequential selection for Kd expression . Six sequential sorts yielded the cell line CVKD-
10 .6. Subsequent selection of Kd-expressing cells yielded no further enhancement of
expression. Cloned cell lines derived from CVKD-10.6 showed no greater stability or
magnitude of Kd expression than the parental line. Cell populations derived from each
sequential sort were tested as target cells for Kd-restricted CTL . For each sort the efficiency
of target cell recognition was directly proportionated to Kd expression as determined by
fluorescence intensity.
Synthetic Peptides.
￿
A synthetic 23-amino-acid oligopeptide corresponding to the amino
acid sequence from the anchor region of the A/JAP/57 HA (see Fig. 5) was produced on
an automated solid-phase peptide synthesizer from Applied Biosystems, Inc. (Foster City,
CA). This hydrophobic peptide was solubilized in 100% DMSO at a concentration of 5
mg/ml and serially diluted into DME without serum to a concentration of 5 Fag/ml for
use in cytotoxicity assays. Control experiments showed that the residual DMSO present
in the peptide preparation used in cytotoxicity assays (0.025-0.00025%) had no effect on
target cell stability or on the specificity or function of cloned CTL. The unfractionated680
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FIGURE 1 . Recognition of influ-
enza virus-infected CVKD-10.6 cells
by murine Kd-restricted CTL clones.
Target cells were infected with
A/JAP/57 or B/Lee viruses and
tested for their susceptibility to lysis
by three HA-secifc CTL clones in
a standard 6-h . 'Cr-release assay. The
clones were used 3 d aftersubculture.
Spontaneous release from target cells
was <20% of total release during the
assay period. E/T cell ratios used in
the assays: 0, 5:1; ®, 20:1 .
peptide was ^-50% pure as estimated from percentage composition of individual amino
acid residues.
TLymphocyte Clones.
￿
The cloned T lymphocytes used in this assay were derived from
BALB/c and CB6F, mice. They are all restricted by H-2K' and directed to the A/JAP/57
HA. Their establishment, maintenance, and antigenic fine specificity have been detailed
in recent publications (14, 16).
Assays for Cell-mediated cytotoxicity.
￿
P815 cells, transfected L cells, and CV-1 cells
expressing the Kd gene product were used as targets in standard "Cr-release assays. These
assays were carried out essentially as described previously (4). For assays using synthetic
peptides, the anchor peptide was diluted in tissue culture medium to the appropriate
concentration and added to a mixture of cloned CTL and target cells in 96-well microtiter
plates. For assays using CVKD-10.6 cells infected with SV40 late replacement vectors as
targets, cells were infected in suspension before plating and incubated for 48-72 h at
37°C to allow maximum HA expression before 'Cr labeling. Cytotoxicity assays were
carried out for 4-6 h as described (11), and the resultant data were analyzed exactly as
described in detail elsewhere (4, 11).
Results
Antigen-speciftc Recognition by Murine CTL of Monkey CV-1 Cells Displaying the
Murine Kd Gene Product. We have previously (20) used transfected L cells that
express the influenza HA gene from a plasmid-based vector to show that the HA
alone, in the absence ofother influenza virus-encoded proteins, can be recognized
by both strain-specific and crossreactive antiinfluenza CTL . However, the effi-
ciency of CTL lysis of the transfected cell line was less than optimum as a result
of the low level of expression of HA. To alleviate this problem and also to allow
testing as target antigens, the full range of HA mutants that have been cloned
into SV40-based vectors (reviewed in reference 19), we decided to generate a
monkey cell line that would be both permissive for infection by SV40 and also
histocompatible for lysis by murine class I MHC-restricted CTL. To this end,
we have introduced the murine H-2K d gene into CV-1 cells under selection for
neomycin resistance (Materials and Methods). Cells that were resistant to the
G418 antibiotic were further selected for cell surface expression of the Kd
molecule by flow cytofluorometry. Several Kd-expressing CV-1 lines were isolated
by this protocol, including the CVKD-10.6 line used here. As demonstrated in
Fig. 1, this Kd-expressing cell line was recognized and destroyed by influenza-
specific murine class I MHC-restricted CTL in an antigen-specific fashion . The
three Kd-restricted CTL clones, 11-1, 14-1, and 14-7, which recognize theBRACIALE ET AL.
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Comparison of the structures of wild-type, anchor-negative, and chimeric forms
of HA. (A) A schematic diagram of the various HA polypeptides. Within the large NH2-
terminal ectodomain of HA lies the trypsin-sensitive site (arrowhead) at which the precursor
molecule can be cleaved into HA1 and HA2 subunits. The mutant proteins differ from the
wild-type at the COOH-terminus; the transmembrane and cytoplasmic domains are absent
(HA-A-) or have been substituted by theanalogous regions of the VSV Gglycoprotein (HA-G)
or the HSV-I C glycoprotein (HA-gC). (B) The COOH-terminal aminoacid sequences of the
wild-type and mutant HA glycoproteins (18).
A/JAP/57 HA (14), efficiently lyseA/JAP/57-infected, but not influenza B/Lee-
infected CVKD-10.6 cells. A/JAP/57-infected parental CV-1 cells were not
susceptible to lysis by these murine CTL clones (see Table IV).
CTL Recognition of Anchor-negative HA.
￿
We first chose to examine class I
MHC-restricted CTL recognition of a secreted form o£ HA that lacks the
hydrophobic transmembrane domain that normally anchors the protein in the
lipid bilayer. A gene encoding this anchor-negative HA has previously been
generated by deletion of the nucleotide sequence corresponding to the mem-
brane-spanning and cytoplasmic portions ofthe HA molecule (18). To facilitate
incorporation of the mutant gene into the expression vector, a short synthetic
oligonucleotide sequence coding for a series of chargcd amino acids was added
at the 3'-end of the truncated cDNA. The COOH-terminal sequence of the
mutant HA is shown in Fig. 2. This truncated HA gene has been previously
shown to be efficiently expressed in CV-1 cells using the SVEHA20-A- late
replacement vector (18).
The results presented in Table I show that two HA-specific CTL clones, 11-1
and 14-1, recognize CVKD-10.6 cells infected with the SVEHA20-A- recombi-
nant virus and do so with an efficiency comparable to that of CVKD-10.6 cells68 2
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TABLE I
CTL Recognition ofthe Products ofAnchor-positive and Anchor-negative HA Genes
* CTL clones were tested for lytic activity in a 6-h 5'Cr-release assay on CVKD-10.6 cells infected
with either the indicated influenza strain (A/JAP/57, B/Lee), a recombination vaccinia virus
containing the A/JAP/57 HA gene [VV(HA)], the SVEHA3 late replacement vector containing
the intact A/JAP/57 HA gene (SVHA-At), or the SVEHA20-A- vector containing the HA gene
lacking the sequences encoding the transmembrane anchor (SVHA-A-).
$ Values are the mean oftriplicate wells; SEM were <5% ofmean valuesand areomitted. Spontaneous
release from all targets was less than 20% of total incorporation. 104 target cells were added per
well.
infected with the SVEHA3 virus that expresses the wild-type A/JAP/57 HA . In
contrast, although clone 14-7 recognizes the parental HA gene productexpressed
either after infection with A/JAP/57 influenza virus or after infection with
recombinant SVEHA3 or vaccinia virus (VV-HA) expression vectors containing
the wild-typeHA gene sequence, it fails to recognize the product of the truncated
anchor-negative HA gene.
It is noteworthy that while HA was readily demonstrable on the surface of
CVKD-10.6 cellsinfected with A/JAP/57 virusor the SVEHA3 vector containing
the parental HA gene, flow cytofluorometric analyses of cells infected with the
SVEHA20-A- vector failed to reveal any cell surface HA (Fig. 3). This result is
consistent with our previous observations that the anchor-negative HA is not
anchored in the lipid bilayer and is not detectable on the surface of infected CV-
1 cell as an integral membrane protein (18). Rather, this mutant protein is
synthesized in the rough endoplasmic reticulum, transported through the Golgi
apparatus and secreted into the medium overlying the infected cells. Thus, the
ability of certain class I MHC-restricted CTL to recognize cells expressing this
secreted HA molecule strongly suggests that display of HA as an integral
membrane constituent is not a necessary requirement for class I MHC-restricted
CTL recognition.
CTL clones 11-1, 14-1, and 14-7 are all Lyt-2+ (16), and as demonstrated
above and elsewhere (14, 16), are HA specific and Kd restricted. However, clones
11-1 and 14-1, which recognize the anchor-negative HA, are directed to an
epitope shared by the A/JAP/57 and serologically closely related HAs of the
H2N2 subtype (14). On the other hand, clone 14-7, which fails to recognize the
anchor-negative form ofthe HA, is more broadly crossreactivewithin the subtype
and recognizes an HA epitope shared by most viruses of the H2N2 subtype (14,
16). In view of this difference in fine specificity between these CTL clones, it
was of interest to examine recognition of the anchor-negative HA by additional
HA-specific CTL clones. The results of this analysis for seven such clones are
Percent specific "Crrelease from infected CVKD-10.6 target
CTL clone E/T ratio cells*
A/JAP/57t SVHA-A' SVHA-A- VV(HA) B/LEE
11-1 5:1 16 6 10 23 0.1
20:1 52 27 35 65 0.4
14-1 5:1 24 9 15 41 0.8
20:1 37 13 20 58 0.3
14-7 5:1 20 12 0.1 36 0.3
20:1 31 16 1 .0 53 0.5BRACIALE ET AL .
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FIGURE 3 . Flow cytofluoromet-
ric analysis of the expression of
HA glycoproteins on the cell sur-
face of CVKD-10.6 cells . CVKD-
10 .6 cells were infected with (A)
A/JAP/57 influenza virus, or (B)
with SV40-HA recombinant vi-
ruses encoding the wild-type
A/JAP/57 HA (SVEHA3), (C)
or the anchor-negative HA
(SVEHA20-A-) . Shaded curves
indicate the fluorescence intensity
profile of infected cells treated
with anti-HA mAb and fluores-
ceinatedsecondaryanti-mouse Ig
antibody . Open curves describe
profiles obtained with secondary
antibody alone .
presented in Table 11 . Five of these clones recognize target cells expressing the
anchor-negative HA, albeit with varying efficiency . As reported by us elsewhere
(14), these clones also recognize strain-specific HA epitopes expressed on the
A/JAP/57 and closely related HAs. In contrast, two other HA-specific clones,
A-4 and C-1, fail to recognize the anchor-negativeHA . Clone A-1, like clone 14-
7, is subtype specific, while clone C-1 recognizes an HA epitope shared by HAs
of the H1N1 and H2N2 subtypes (14) .
CTL Recognition of Chimeric HA Genes Containing Unrelated Anchor Se-
quences .
￿
There are two possible explanations for the lack of recognition of the684
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TABLE 11
Anchor-negative Hemagglutinin Recognition and CTL Fine Specificity
* As in Table 1. E/T cell ratio was 20:1 in all cases.
As in Table 1.
anchor-negative HA by clones 14-7, A-4, and C-1. First, these clones could
recognize epitopes encoded by the nucleotide sequence corresponding to the
deleted transmembrane or cytoplasmic domains of the HA polypeptide (Fig. 2).
Alternatively, the tertiary structure of the anchor-negative HA product might
be altered as a result of the lack of membrane anchorage, resulting in selective
loss of conformational epitopes recognized by these three HA-specific CTL
clones. To examine this latter possibility, we analyzed the recognition of cells
expressing chimeric HA gene constructs in which the sequences encoding the
transmembrane and cytoplasmic domains of HA have been replaced by the
corresponding domains from either the HSV-1 glycoprotein C (SVHA-gC) or
the VSV G protein (SVHA-G) . Previous experiments (19) have demonstrated
that these chimeric proteins are anchored in the lipid bilayer and transported to
the cell surface where they are displayed in an antigenically and biologically
active form. The structures of these molecules are shown in Fig. 2. The results
presented in Table III demonstrate that clones 14-7, A-4, and C-1 fail to
recognize CVKD-10.6 cells expressing thechimeric HA gene products, indicating
that recognition by these clones is not reestablished by anchoring the HA
ectodomain in the plasma membrane. Three other HA-specific clones, 11-1, 40-
1, and 40-2, which recognize the parental HA gene product and the anchor-
negative HA, do recognize the products of the chimeric HA constructs with
comparable efficiency.
CTL Recognition ofa Synthetic Peptide Corresponding to the Anchor Domain ofthe
HA. The results described above support the view that the three clones that
fail to recognize the anchor-negative HA might be directed to sequences located
within the deleted transmembrane and/or cytoplasmic domains of the A/JAP/57
HA . To address this possibility directly, we synthesized a synthetic peptide
correspondingto 23 amino acid residues encompassing the less-conserved portion
of the transmembrane region of the A/JAP/57 HA (Fig. 4) and examined the
capacity of a panel of Kd-restricted, HA-specific CTL clones of different fine
specificity to recognize target cells sensitized with this peptide. Choice of the
peptide was made after consideration of the evidence that although clones 14-7
and A-4 both recognize an epitope (or epitopes) contained within the transmem-
brane and cytoplasmic domains of the A/JAP/57 HA, they do not recognize cells
CTL clone
Percent specific "Cr release
10.6
A/JAP/57t SVHA-A'
from infected
targets*
SVHA-A-
CVKD-
B/LEE
17-2 36 13 9 0.2
17-4 38 13 10 0
40-1 44 38 34 1
40-2 27 22 23 0.2
40-4 33 31 27 0.5
A-4 17 10 1 0
C-1 29 20 1 0.7BRACIALE ET AL.
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TABLE III
CTL Recognition ofChimeric HA Gene Products Containing Unrelated Anchor Sequences
* As in Table I. SVHA-gCand SVHA-G represent SV40 vectors containing chimeric gene sequences
encoding the extracellular portion of the A/JAP/57 HA linked to the membrane-spanning and
cytoplasmic regions of the herpes simplex I gC and VSV-G proteins. (See Materials and Methods
and Fig. 2.)
As in Table I.
from the nucleic acid sequences of cloned cDNAs. The sequence of the anchor-negative mutant of
the A/JAP/57 HA has been reported previously (17). (F-TM-*) The residues encompassing the
membrane spanning anchor sequence,as deduced by comparison of thepositions of charged or polar
amino acids in the corresponding regions of HAs from different virus strains. (+-CY-)') Residues
located in thecytoplasmic compartment of thecell. The residues represented in the synthetic peptide
used in sensitization studiesare indicated on the A/JAP/305/57 HA sequence.
expressing the A/PR8/34 HA. Comparison ofthe amino acid sequences ofthese
two HAs (Fig. 4) shows that the cytoplasmic tail and the COON-terminal portion
of the transmembrane domain are totally conserved so that sequence divergence
is evident only within the remainder ofthe transmembrane region. The peptide
was designed to correspond to this less-conserved portion of the A/JAP/57 HA
sequence.
The results shown in Fig. 5 indicate that nine CTL clones that recognize
CVKD-10.6 cells expressing the product of the anchor-negative gene construct
all fail to recognize target cells sensitized with the anchor peptide. However, the
three clones (14-7, A-4, and C-1) that failed to recognize the anchor-negative
HA product efficiently recognized peptide-treated target cells. Sensitization of
target cells with the synthetic anchor peptide was dose dependent. The results
presented in Fig. 6 show that sensitization was achieved at peptide concentrations
as low as 12.5 ng/ml (4.5 nM) and was optimum at peptide concentrations 10-
100-fold higher. Furthermore, anchor-specific CTL clones recognize target cells
treated with the anchor peptide in an MHC-restricted fashion (Table IV). The
CTL clone E/T ratio
Percentspecific
A/JAP/57T
"Crrelease
SVHA-A+
from infected
SVHA-A -
CVKD-10.6
SVHA-gC
target cells*
SVHA-G
11-1 5:1 32 17 19 26 21
20 :1 51 25 28 37 31
40-1 5:1 49 45 40 50 41
20:1 75 68 66 74 67
40-2 5:1 35 31 27 38 33
20:1 61 53 56 62 56
14-7 5:1 28 15 0.7 0.6 0.1
20:1 53 25 1 2 1
A-4 5:1 21 10 0.5 0.2 0
20:1 43 17 1 1 1
C-1 5:1 27 18 1 2 1
20:1 43 26 2 2 1
TM --*--CY-i
FIGURE 4. Comparison of the
Synthetic peptide aminoacid sequencesofthetrans-
membrane and cytoplasmic do-
. . .SMGVYQILAIYATVAGSLSLAIMIAGISFWMCSNGSLQCRICI A/JAP/305/57 HA mains of the A/JAP/57 and
A/PR/8 HA glycoproteins. The
. . .SMGIYQILAIYSTVASSLVLLVSLGAISFWMCSNGSLQCRICI A/PR/8/34 HA COOH-terminal sequencesof the
A/JAP/305/57 and A/PR/8/34
. . .SMGVYPPPGSRHDKIH A/JAP/305/57 HA-A- HA glycoproteins were deduced686
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Specific sensitization of target cells by a syntheticanchor peptide. 1`815 cells (H-
2d) were screened for lysis by the indicated HA-specific CTL clones in the presence of the
syntheticanchor peptide. TheE/Tratiowas5: I. Thesynthetic peptide waspresent throughout
thecourse ofthe 6-h assayat a concentration of 1,250 ng/ml.
FIGURE 6.
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Dose dependence of target cell
sensitization by the synthetic anchor pep-
tide. The E/T cell ratio for the indicated
anchor-specific CTL clones (C-1 and 14-7)
o t-1
￿
is 5:1 . 1`815target cells were incubatedwith
014-7
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ID 11-1
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two anchor-specific CTL clones, I4-7 and C-I, recognized both the transfected
L cells (cell line K7-74) expressing the Kd gene product as well as the Kd-
expressing CVKD-10.6 line sensitized with the synthetic anchor peptide, and
failed to recognize parent L cells (K2) or CV-1 cells treated with the same
peptide. These CTL clones fail to recognize target cells treated with peptides
corresponding to unrelated sequences within the A/JAP/305/57 HA molecule
(Braciale, T. J., unpublished observations).
In this report we have examined the role of the membrane-spanning hydro-
phobic anchor sequence of the HA glycoprotein of influenza virus in the
formation of the target antigen/MHC complex recognized by class I MHC-
restricted influenza HA-specific CTL. For these studies we used a panel of H-
2Kd-restricted influenza HA-specific CTL clones as effectors. Kd-expressing CV-
1 cells infected with SV-40-based expression vectors containing different HA
constructions were tested as targets for CTL recognition. The majority of the
HA-specific CTL clones that were examined recognize target cells expressing aBRACIALE ET AL.
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TABLE IV
MHC Restriction of Target Cell Sensitization by Synthetic Anchor Peptide
* As in Table I. Target cells were either infected with A/JAP/57 virus or exposed to the 23-residue
synthetic anchor peptide (final peptide concentration, 1.25 tug/ml) fortheduration of the assay.
truncated HA gene that lacks the DNA sequence corresponding to the trans-
membrane and cytoplasmic domains of the HA molecule. Thus, expression ofa
gene that encodes an HA molecule that can be anchored in the lipid bilayer is
not an obligate requirement for display of the HA gene product in a form
recognizable by class I MHC-restricted CTL.
Although a transmembrane sequence is not required for recognition of HA
by class I MHC-restricted CTL, our analyses indicate that a subpopulation of
the HA-specific CTL recognize epitopes(s) located within the transmembrane
domain of the molecule . Thus three CTL clones that failed to recognize either
the anchor-negative HA orchimeric HA moleculesthat contain anchor sequences
from unrelated proteins could lyse target cells sensitized by a synthetic peptide
corresponding to part of the membrane-spanning anchor sequence. Sensitization
by this anchor peptide was specific since only those CTL clones that did not
recognize the anchor-negative HA were able to recognize peptide-treated target
cells. Furthermore, synthetic peptides corresponding to other distinct regions of
the HA have so far failed to sensitize histocompatible target cells for recognition
by these anchor-specific CTL clones (Braciale, T. J., unpublished observations).
Two of the three anchor-specific CTL clones have previously been shown to
be directed to an epitope common to most type A influenza viruses ofthe H2N2
subtype, while the third clone (C-1) was shown to recognize an HA epitope
shared by viruses of the HINT and H2N2 subtypes (14). The amino acid
sequences of the transmembrane domains of the A/JAP/305/57 and the
A/PR/8/34 HA molecules are sufficiently homologous to account for the shared
epitope defined by the C-1 clone, yet divergent enough to contain the epitopes(s)
recognized by the subtype-specific clones 14-7 and A-4 (Fig. 5). Experiments are
now in progress to better define these epitopes.
A critical issue raised by our observations relates to the structure of the
Exp. CTL clone E/T ratio
Percent specific "Cr release from target
CVKD-10.6 CVKD-10.6 CV-1
A/JAP/57 Peptide A/JAP/57
cells*
CV-1
Peptide
1 14-7 5:1 12 11 0.9 0.5
20:1 33 34 0.5 0.3
C-1 5:1 22 20 0.2 2
20:1 41 32 0.3 2
K7-74(Kd) K7-74(Kd) K2 K2
A/JAP/57 Peptide A/JAP/57 Peptide
2 11-1 5:1 39 0 0.4 0.9
20:1 49 1 1 2
14-7 5:1 38 47 1 1
0:1 43 67 2 3
C-1 5:1 47 46 0.8 3
20:1 51 59 2 6688
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antigenic moieties on virus-infected cells recognized by class I MHC-restricted
CTL. Early studies on CTL recognition of viral antigens favored the view that
CTL target antigens needed to be displayed on the surface of virus-infected cells
in their native form to render the cells susceptible to CTL-mediated lysis (22-
25). More recently, Townsend et al. (8, 9) have proposed that, rather than
recognizing the native viral antigens, class I MHC-restricted CTL recognize
processed forms of these antigens. Their reported results concerning class I
MHC-restricted CTL recognition of target cells that express the product of an
HA gene lacking the sequence for the signal peptide (26), as well as our present
findings on CTL recognition ofthe anchor-negative HA, are difficult to reconcile
with recognition of the HA glycoprotein in its native form. Our identification of
sequences located within the transmembrane domain as potential epitopes for
CTL recognition also appears to exclude the native membrane bound form of
HA as the obligatory target antigen for CTL and strongly favors the processing
hypothesis.
Several groups have recently reported that class I MHC-restricted CTL (9,
10, 27, 28) or alloreactive class I MHC-specific CTL (29) can recognize synthetic
peptides corresponding to portions of the viral or MHC target antigens. Our
finding that a synthetic peptide corresponding to part of the transmembrane
domain of HA can sensitize target cells for HA-specific CTL confirms and
extends these observations to the influenza HA. In light of these results, it is
attractive to consider that peptide fragments of endogeneously synthesized HA
are the antigenic moieties recognized by class I MHC-restricted CTL on the
surface of influenza-infected cells. The recent demonstrations of direct interac-
tions between synthetic peptide fragments of antigens and H-2 I region products
(2, 3) suggest a structural basis for restricted recognition by class II MHC-
restricted T lymphocytes that may be necessary but not sufficient for T lympho-
cyte triggering. In view of the similarity of the T cell receptor genes. used by
both class I and class II MHC-restricted T lymphocytes (30), a direct interaction
between a viral peptide and class I MHC products might also be a necessary step
in restricted recognition by class I MHC-restricted T lymphocytes. In this regard,
an important issue raised by our results concerns the mechanism by which an
extremely hydrophobic peptide such as that used in these studies (Fig. 4) could
directly interact with and form a stable complex with the Kd gene product on
the cell surface. At present, the precise nature of the antigenic moiety recognized
by these anchor-specific CTL clones on the surface of influenza-infected cells is
open to speculation. It is noteworthy however, that all three anchor-specific CTL
clones fail to efficiently recognize thenative HA polypeptide when it is introduced
exogeneously into the target cells as part of noninfectious influenza virions or as
the isolated intact protein (4 and our unpublished observations). This is consistent
with our previous observation that class I MHC-restricted CTL preferentially
recognize HA moieties synthesized de novo in target cells rather than exogenously
introduced intact HA (4).
Studies of Wabuki-Bunoti et al . (6, 31, 32) have implicated at least two other
sites on the A/JAP/57 HA as potential class I MHC-restricted CTL target
epitopes. These amino acid sequences were defined at the level of induction of
proliferation of class I MHC-restricted CTL responses and have not as yet beenBRACIALE ET AL.
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formally mapped at the level oftarget cell sensitization. Several distinct regions
of the HA (within the HA1 subunit) have also been mapped as recognition sites
of Class II MHC-restricted T lymphocytes (e.g., references 33, 34). We have
examined a large panel of class II MHC-restricted HA-specific T lymphocyte
clones for recognition of the synthetic anchor peptide and to date have failed to
detect any anchor specific H-2I region-restricted T lymphocytes (L. Morrison,
unpublished observations). Although still preliminary, this failure may reflect
the inability of the anchor sequence to interact with certain Class II MHC
products (2, 3, 35). Alternatively, since HA appears to bepreferentiallypresented
to class II MHC-restricted T lymphocytesby an exogenouspresentation pathway
(4), it is possible that the anchor sequence is not preserved during the processing
ofthe HA glycoprotein throughthatputative endocyticpathway. Further analysis
will be required to distinguish among these and other possibilities.
In conclusion, in this report we have demonstrated that display of de novo
synthesized influenza HA protein as an integral constituent of the target cell
plasma membrane is not required for target cell recognition by class I MHC-
restricted CTL. Furthermore, amino acid residues located within the transmem-
brane anchor sequence of the A/JAP/57 HA appear to define antigenic epitopes
for subtype-specific as well as crossreactive class I MHC-restricted CTL clones.
These findings are consistent with the view that class I MHC-restricted T
lymphocytes may recognize a nonintegral form of HA synthesized de novo and
displayed by an endogeneous presentation pathway, while class II MHC-re-
stricted T lymphocytes preferentially recognizeantigens that have been modified
after introduction into presenting cells via an exogenous pathway (4, 36).
Summary
We have examined the requirement for the transmembrane hydrophobic
anchor sequence of the influenza hemagglutinin (HA) in the formation of the
antigenic moiety on the surface of target cells recognized by class I MHC-
restricted murine CTL. For this analysis we have used a line of CV-1 monkey
epithelial cells that express the transfected murine H-2Kd gene product as target
cells and have used recombinant SV40-based late replacement vectors to achieve
expression ofgenesencoding wild-typeand mutant forms ofHA. We have found
that the majority of Kd-restricted HA-specific CTL clones recognize target cells
that express a secreted HA molecule that lacks the transmembrane and cyto-
plasmic domains of the parent glycoprotein . Several Kd-restricted CTL clones
that recognize subtype-specific and crossreactive epitopes on HA fail to recognize
the anchor-negative, secreted HA or chimeric HA molecules containing the
transmembraneandcytoplasmicdomains ofunrelatedglycoproteins. These CTL
clones appear to be directed to antigenic epitopes located within the transmem-
brane domain of HA, as defined by their capacity to recognize target cells
sensitized with a synthetic 23-amino-acid peptide corresponding to sequences
within this domain. The implications of these results for class I MHC-restricted
CTL recognition are discussed.
The authors wish to thank Dr. Gregory Grant and Mark Frazier and their colleagues at
the Protein Synthesis Facility, Washington University School of Medicine for the prepa-690
￿
HEMAGGLUTININ ANCHOR RECOGNITION BY T LYMPHOCYTES
ration of the anchor peptide and Jerri Smith and Catherine Hamby for patient and
dedicated secretarial assistance in preparation of the manuscript.
Receivedfor publication 18 May 1987.
References
1 . Zinkernagel, R. M., and P. D. Doherty. 1979. MHC-restricted cytotoxic T cells:
studies on the biological role of polymorphic major transplantation antigens deter-
mining T cell restriction specificity, function, and responsiveness. Adv. Immunol.
27:52.
2. Babbitt, B., P. M. Allen, G. Matsueda, E . Haber, and E. R. Unanue. 1985. Binding
of immunogenic peptides to la histocompatibility molecules. Nature (Lond.). 317 :359.
3. Buus, S ., A. Sette, S. M . Conlon, D . M . Jenis, and H. Grey. 1986. Isolation and
characterization of antigen-la complexes involved in T cell recognition. Cell. 47 :1071 .
4. Morrison, L. A., A. Lukacher, V . L. Braciale, D. P. Fan, and T . J. Braciale. 1986.
Differences in antigen presentation to MHC class I and class 11-restricted influenza
virus specific cytolytic T lymphocyte clones. J. Exp. Med. 163:903.
5. Guertin, D. P., and D. P. Fan . 1980 . Stimulation ofcytolytic T cells by isolated viral
peptides and HW protein coupled to agarose beads. Nature (Lond.). 283:308.
6. Wabuke-Bunoti, M., D. P. Fan, and T. J. Braciale. 1981 . Stimulation of anti-influenza
cytolytic T lymphocytes by CNBr cleavage fragments of the viral hemagglutinin. J.
Immunol. 127:1122.
7. Gooding, L. R., and K. A. O'Connell . 1983. Recognition by cytotoxic T lymphocytes
of cells expressing fragments of the SV40 tumor antigen. f. Immunol. 131 :2580.
8. Townsend, A. R. M., R. M. Goth, and J. Davey. 1985. Cytotoxic T cells recognize
fragments of the influenza nucleoprotein. Cell. 42:457 .
9. Townsend, A. R. M ., J. Rothbard, F. M . Gotch, G. Bahadur, D. Wraith, and A . J.
McMichael. 1986 . The epitopes of influenza nucleoprotein recognized by cytotoxic
T lymphocytes can be defined with short synthetic peptides. Cell. 44:959.
10. Maryanski, J. L., P. Pala, C. Corradin, B. R. Jordan, and J. C. Cerrotini. 1986. H-2
restricted cytolytic T cells specific for HLA can recognize a synthetic HLA peptide.
Nature (Lond.). 324:578 .
11 . Braciale, T. J. 1977. Immunologic recognition of influenza virus-infected cells. 1 .
Generation of a virus strain-specific and a cross-reactive subpopulation of cytotoxic
T cells in the response of type A influenza viruses of different subtypes. Cell. Immunol.
33:423.
12. Doyle, C., M . G. Roth, J. Sambrook, and M.J. Gething. 1985. Mutations in the
cytoplasmic domain of the influenza hemagglutinin affect different stages of intra-
cellular transport.J. Cell Biol. 100:704.
13 . Smith, G. L., B. R. Murphy, and B. Moss. 1983 . Construction and characterization
ofan infectious vaccinia virus recombinant that expresses the influenza hemagglutinin
gene and induces resistance to influenza virus infection in hamsters. Proc. Natl. Acad.
Sci. USA. 80:7155.
14. Braciale, T. J ., T. J. Henkel, A. E. Lukacher, and V . L. Braciale. 1986. Fine specificity
and antigen receptor expression among influenza virus-specific cytolytic T lympho-
cyte clones. J. Immunol. 137:995 .
15 . Goodenow, R. S., I. Stroynowski, M. McMillan, M. Nicolson, K . Eakle, B. T. Sher,
N. Davidson, and L. Hood . 1983. Expression of complete transplantation antigens
by mammalian cells transformed with truncated class I genes. Nature (Lond.). 301 :388.
16. Braciale, T. J., M . E. Andrew, and V. L. Braciale. 1981 . Heterogeneity and specificityBRACIALE ET AL.
￿
69 1
of cloned lines of influenza-virus-specific cytotoxic T lymphocytes. J. Exp. Med.
153 :910.
17 . Gething, M.J., and J . Sambrook. 1981 . Cell-surface expression of influenza hemag-
glutinin from a cloned DNA copy of the RNA gene. Nature (Lond.). 293:620 .
18 . Gething, M. J., and J . Sambrook. 1982 . Construction of influenza hemagglutinin
genes that code for intracellular and secreted forms of the protein. Nature (Lond.).
300:598.
19 . Roth, M ., M .J . Gething, and J. Sambrook. 1987. Intracellular transport and mem-
brane insertion of the influenza virus glycoproteins. In The Influenza Viruses. R. M.
Krug, editor. Plenum Publishing Corp., New York. In press.
20 . Braciale, T . J ., V. L. Braciale, T. J. Henkel, J . Sambrook, and M .J . Gething. 1984.
Cytotoxic T lymphocyte recognition of the influenza hemagglutinin gene product
expressed by DNA-mediated gene transfer. J. Exp. Med. 159:341 .
21 . Andrew, M . E., A. M. Churilla, T . R. Malek, V. L. Braciale, and T . J. Braciale. 1985.
Activation of virus specific CTL clones: antigen-dependent regulation of interleukin
2 receptor expression . J. Immunol. 134:920.
22 . Sugamura, K., R. Shemezu, J. Zarling, and F. H. Bach. 1977. Role of Sendai virus
fusion-glycoprotein in target cell susceptibility to cytotoxic T cells. Nature (Lond.).
270:25.
23 . Gething, M .J., V. Koszinowski, and M. Waterfield. 1978 . Fusion of Sendai virus with
the target membrane is required for T cell cytotoxicity. Nature (Lond.). 275 :689.
24. Braciale, T. J., and K. L. Yap. 1978. Role of viral infectivity in the induction of
influenza virus-specific cytotoxic T cells. J. Exp. Med. 147:1236.
25 . Kurrle, R., H. Wagner, M . Rollinghoff, and R. Rott. 1979. Influenza virus-specific
T cell-mediated cytotoxicity: integration of the virus antigen into the target cell
membrane is essential for target cell formation. Eur. J. Immunol. 9:107.
26 . Townsend, A., J. Bastin, K. Gould, and G. Brownlee. 1986. Cytotoxic T lymphocytes
recognize influenza hemagglutinin that lacks a signal sequence. Nature (Lond.).
324 :575.
27 . McMichael, A., F . Gotch, and J . Rothbard. 1986. HLA B37 determines an influenza
A virus nucleoprotein epitope recognized by cytotoxic T lymphocytes. J. Exp. Med.
164 :1397.
28 . Parham, P., C. Clayberger, S. Zorn, D. Ludwig, G . Schoolnik, and A. M . Krensky.
1987 . Inhibition of alloreactive cytotoxic T lymphocytes by peptides from the a2
domain of HLA-A2. Nature (Loud.) . 325:625 .
29 . Gotch, F., J. Rothbard, K. Howland, A. Townsend, and A. McMichael . 1987.
Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in
association with HLA-A2. Nature (Lond.). 326:881 .
30 . Kronenberg, M ., G. Sui, L. E. Hood, and N . Shastuk. 1986 . The molecular genetics
of the T cell antigen receptor and T cell antigen recognition. Annu. Rev. Immunol.
4:529.
31 . Wabuke-Bunoti, M. A. N ., and D. P. Fan. 1983. Isolation and characterization of a
CNBr cleavage fragment of influenza viral hemagglutinin stimulatory for mouse
cytolytic T lymphocytes. J. Immunol. 130:2386.
32 . Wabuke-Bunoti, M., A. Taku, D. Fan, S. Kent, and R. Webster. 1984. Cytolytic T
lymphocyte and antibody responses to synthetic peptides of influenza virus hemag-
glutinin . J. Immunol. 133:2194.
33 . Hackett, C. J., B. Dietzschold, W . Gerhard, B. Ghrist, R. Knorr, D. Gillessen, and F.
Melchers. 1983 . Influenza virus site recognized by a murine helper T cell specific
for H 1 strains: localization to a nine amino acid sequence in the hemagglutinin
molecule. J. Exp. Med. 158 :294.692
￿
HEMAGGLUTININ ANCHOR RECOGNITION BY T LYMPHOCYTES
34. Lamb, J. R., D. Eckels, P. Lake, J. N. Wooody, and N. Green. 1982 . Human T-cell
clones recognize chemically synthesized peptides of influenza hemagglutinin. Nature
(Lond.). 300 :66 .
35. Guillet, J.-G., M .-Z . Lai, T. Briner, S. Buus, A. Sette, H. Grey, J . A. Smith, and M .
Gefter. 1987. Immunological self, nonself discrimination. Science (Wash. DC).
235:865.
36. Braciale, T. J., L. A . Morrison, M . T. Sweetser, J. Sambrook, M.-J. Gething, and V.
L. Braciale. 1987. Antigen presentation to class I and class II MHC-restricted T
lymphocytes. Immunol. Rev. In press.